We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Submit a Manuscript to the Journal

New Genetics and Society

For an Article Collection on

Prenatal Screening

Manuscript deadline
31 July 2023

Cover image - New Genetics and Society

Article collection guest advisor(s)

Prof. Felicity Boardman, University of Warwick
[email protected]

Prof. Ruth Horn, University of Oxford
[email protected]

Submit an ArticleVisit JournalArticles

Prenatal Screening

Prenatal screening and testing includes all forms of testing (of both the foetus and pregnant person) that occur during a pregnancy, both as part of standardised antenatal screening programmes, as well as targeted and diagnostic testing where known ‘risk’ factors exist.

Recent developments in the field of genomic medicine, together with the widespread availability of Non-Invasive Prenatal Testing (the analysis of cell-free fetal DNA from maternal blood), however, are increasingly challenging the overarching aims and remit of prenatal testing and screening. Shifts towards the use of broad assay approaches in reproductive genetics (e.g. whole genome/exome sequencing) mean that the sheer scale and complexity of information that can now be made available through prenatal testing and screening is rapidly expanding.

In addition to these shifts, the legislation surrounding pregnancy termination following prenatal testing has recently come under critical scrutiny. Heidi Crowter’s 2022 legal case, for example (which was launched to demand human rights and legal protections of disabled foetuses), highlighted oppositional tensions between women’s rights and those of disabled people. This framing- of an antagonistic relationship between women, as users of prenatal screening programmes, and disabled people, whose lives were seen to be disvalued through their existence- has shaped much of the ensuing public debate around the role of prenatal screening within inclusive societies.

This collection takes these timely, and still emerging, social and ethical tensions surrounding expansive prenatal screening and testing practices-and the needs and rights of both pregnant and disabled people therein- as its point of departure. By demonstrating the contested conceptual landscape on which prenatal screening programmes are premised- for example, in the construction of what constitutes ‘valuable’ or ‘actionable’ information in prenatal contexts, and to whom this information should be made available- this collection aims to illuminate the complexities of the policy and legal context in which prenatal screening and testing practices are situated, and the varied lived experiences to which they give rise.

New Genetics and Society accepts original research articles. When submitting your article, please select the Article Collection "Prenatal Screening" from the drop-down menu in the submission system.

Benefits of publishing open access within Taylor & Francis

Global marketing and publicity, ensuring your research reaches the people you want it to.

Article Collections bring together the latest research on hot topics from influential researchers across the globe.

Rigorous peer review for every open access article.

Rapid online publication allowing you to share your work quickly.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.